In one paragraphArticle in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Ivy RukashaDivision of Medical Microbiology, Department of Pathology, School of Medicine, University of Limpopo, Polokwane 0727, South Africa.ORCID 0000-0002-6279-6409 Kabelo Gabriel KaapuDivision of Medical Microbiology, Department of Pathology, School of Medicine, University of Limpopo, Polokwane 0727, South Africa.ORCID 0000-0002-5351-7834 Nakamozi Francine NemaguvhuniMultidrug Resistant Tuberculosis Unit, Tshilidzini Hospital, Limpopo Department of Health, Limpopo 0950, South Africa.
Felicia Wells-HunterSouth African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South Africa.ORCID 0000-0001-8569-0183 Abhinav SharmaSouth African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South Africa.ORCID 0000-0002-6402-6993 Jody Emile PhelanDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Mutlisi Jacqueline KolobeDepartment of Microbiology, National Health Laboratory Service, Polokwane 0699, South Africa.
Molebogeng Ruth Lekalakala-MokabaDivision of Medical Microbiology, Department of Pathology, School of Medicine, University of Limpopo, Polokwane 0727, South Africa.ORCID 0000-0001-8560-8581 Robin Mark WarrenSouth African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South Africa.ORCID 0000-0001-5741-7358 Emilyn Costa ConceiçãoSouth African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South Africa.ORCID 0000-0002-7445-6620 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Nontuberculous mycobacteria (NTM) pose significant diagnostic challenges in high tuberculosis (TB)-burden settings, particularly when routine molecular assays suggest multidrug-resistant TB (MDR-TB). Current diagnostic algorithms in high TB-burden settings are primarily designed to detect members of the
Indexed as
Limpopomultidrug-resistant tuberculosisnontuberculous mycobacteria
Identifiers
PMID42514100
PMCPMC13414386
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390